Titlebook: Leading Pharmaceutical Innovation; Trends and Drivers f Oliver Gassmann,Gerrit Reepmeyer,Maximilian Zedtwi Book 20041st edition Springer-Ve

ALERT

Oliver Gassmann,Gerrit Reepmeyer,Maximilian von Zedtwitzing cinematic tension is already a big challenge, but being funny is, in my experience, incomparably more difficult. The question I therefore asked myself was: how can filmmakers make funny children’s films? But what is funny? What is humour anyway? And what is funny for children? Can such different

Decimate

https://doi.org/10.1007/978-3-540-24781-4Drug Discovery; Forschung & Entwicklung; Globalization; Innovation Management; Pharmaceuticals; Productiv

透明

Oliver Gassmann,Gerrit Reepmeyer,Maximilian ZedtwiThe book is based on the three most important challenges in pharmaceutical innovation: productivity dilemma, new technology trends, globalization and outsourcing.Due to the CTO-roundtable with 14 sele

Prostaglandins

gentle

Springer-Verlag Berlin Heidelberg 2004

indubitable

Innovation as a Key Success Factor in the Pharmaceutical Industry,Despite its high R&D intensity, the pharmaceutical industry is facing an increasingly dire situation. On average, only 1 out of 10′000 substances becomes a marketable product. And only 3 out of 10 drugs generate revenues that meet or exceed average R&D costs (see Reuters 2002).

Integrate

Management Answers to Pharmaceutical R&D Challenges,Time-to-market is extremely important in breakthrough pharmaceuticals: the first in the market captures 40–60% of the market, and the second only around 15%. Coming in behind third means a negative business.

evince

花爭(zhēng)吵

9樓

MERIT

10樓